Full Text View
Tabular View
No Study Results Posted
Related Studies
New Antibiotic to Treat Patients With Community-Acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
This study has been completed.
Study NCT00035269   Information provided by Pfizer
First Received: May 2, 2002   Last Updated: July 2, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pneumonia, Pneumococcal
Community Acquired Infections
Gram-Positive Bacterial Infections
Additional conditions recognized in this trial
Bacterial Infections
Communicable Diseases
Community-Acquired Infections
Infection
Pneumonia
More general conditions related to this trial
Lung Diseases
Pneumococcal Infections
Pneumonia, Bacterial
Respiratory Tract Diseases
Respiratory Tract Infections
Streptococcal Infections
Interventions listed in this trial
Antibiotic
Additional drug interventions recognized in this trial
Anti-Bacterial Agents
More general drug interventions related to this trial
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services